HOMO SANUS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 84,972 | 103,205 | 78,140 | 115,143 | 91,122 | 119,515 | 84,108 | 73,689 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 4,940 | 10,208 | 12,039 | 15,002 | -16,954 | 6,467 | -6,523 | -1,680 |
| Equity | 8,242 | 13,510 | 15,350 | 16,567 | -387 | 6,080 | -443 | -2,122 |
| Liabilities | 12,026 | 8,325 | 2,671 | 2,681 | 6,844 | 4,061 | 9,929 | 2,999 |
| Non-current assets | 18,023 | 16,311 | 15,039 | 11,363 | 5,593 | 2,215 | 1,057 | 516 |
| Current assets | 2,245 | 5,524 | 2,527 | 7,885 | 830 | 7,871 | 8,305 | 301 |
| Total assets | 20,268 | 21,835 | 17,566 | 19,248 | 6,423 | 10,086 | 9,362 | 817 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 10,163 | 6,625 | 6,688 |
| Social insurance contributions | - | - | - | - | - | 9,163 | 7,732 | 7,777 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +28.1% | +21.5% | -24.3% | +47.4% | -20.9% | +31.2% | -29.6% | -12.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 24.4% | 46.8% | 68.5% | 77.9% | -264.0% | 64.1% | -69.7% | -205.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 59.9% | 75.6% | 78.4% | 90.6% | - | 106.4% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.8% | 9.9% | 15.4% | 13.0% | -18.6% | 5.4% | -7.8% | -2.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.5 | 0.6 | 0.2 | 0.2 | - | 0.7 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 14,567 | 20,641 | 17,364 | 23,029 | 18,533 | 24,727 | 17,107 | 18,422 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
HOMO SANUS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-23 | 2025-11-16 | 0.01 |
| 2025-08-28 | 2025-08-29 | 1.01 |
| 2025-08-19 | 2025-08-24 | 1.01 |
| 2025-07-16 | 2025-08-06 | 1.01 |
| 2024-08-19 | 2024-09-10 | 0.30 |
| 2024-07-24 | 2024-08-11 | 0.29 |
| 2024-04-16 | 2024-04-16 | 499.40 |
| 2022-05-17 | 2022-05-18 | 0.18 |
| 2022-04-28 | 2022-05-10 | 0.18 |
| 2021-11-16 | 2021-12-14 | 0.01 |
HOMO SANUS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-02-20 | 2025-02-27 | 5.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
HOMO SANUS, UAB (code 134391247) is a Private Limited Liability Company active in medical specialists activities. In 2025, the company generated revenue of €73.7K, down 12.4% year on year and 38.3% below the 2023 level of €119.5K. Net profit was a loss of €1.7K in 2025, following a loss of €6.5K in 2024 after a profit of €6.5K in 2023. The 2025 profit margin was -2.3%, showing a modest improvement versus 2024 but still negative. The balance sheet remained very small: total assets were €817, equity was -€2.1K and liabilities were €3.0K. Long-term assets amounted to €516 and short-term assets to €301. Profitability ratios were heavily affected by the very small and negative equity and asset base, so they should be read as distorted rather than structurally strong. Revenue per employee was €18.4K, while profit per employee was -€420, indicating limited operating scale and weak earnings in 2025.